http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102149565-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-545 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-73 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57492 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 |
| filingDate | 2013-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-102149565-B1 |
| titleOfInvention | Anti-human dlk-1 antibody having anti-tumor activity in vivo |
| abstract | The present invention specifically reacts with hDlk-1 and has anti-tumor activity in vivo (anti-hDlk-1 antibody, especially humanized antibody), fragments of the antibody, hybridomas producing the antibody, and the antibody Or a complex of an antibody fragment and a drug, a pharmaceutical composition containing the antibody, etc., a tumor therapeutic agent, a tumor diagnostic agent, a tumor cell apoptosis inducing agent, a tumor treatment method, a tumor detection method, a tumor cell apoptosis induction method, a tumor detection And/or diagnostic kits, and kits for inducing apoptosis of tumor cells. |
| priorityDate | 2012-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 922.